Literature DB >> 10211101

Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma.

M Tomisawa1, T Tokunaga, Y Oshika, T Tsuchida, Y Fukushima, H Sato, H Kijima, H Yamazaki, Y Ueyama, N Tamaoki, M Nakamura.   

Abstract

Vascular endothelial growth factor (VEGF) has five isoforms (VEGF206, 189, 165, 145 and 121). Increased VEGF expression in renal cell carcinoma (RCC) is associated with angiogenesis, but, it is not apparent which isoform is involved in this effect. We examined the isoform patterns of VEGF by reverse transcription-polymerase chain reaction (RT-PCR) in 47 RCCs. All showed increased VEGF expression as compared with extraneoplastic renal tissue. Four of the 47 RCCs showed VEGF121 alone, 10 showed VEGF121 + 165, and 33 showed the VEGF121 + 165 + 189 pattern. Patients with pathological stage pT3-4 RCC showed the VEGF121 + 165 + 189 isoform pattern at a significantly higher incidence (10/10, 100%) than those with pT0-2 (23/37, 62%) (P < 0.022). The VEGF121 + 165 + 189 isoform pattern was also significantly associated with high vessel counts and density (P = 0.0002, Mann-Whitney U test). These observations suggested that the VEGF189 mRNA isoform is closely associated with angiogenesis and results in the growth of RCC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211101     DOI: 10.1016/s0959-8049(98)00278-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells.

Authors:  Hai B Zhou; Yi F Yin; Yan Hu; Xin Li; Li Y Zou; Yong J Li; Yu Gu; Bao Q Ou; Juan Fu; Jun H Du; Gang Wu
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

3.  Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

Authors:  O Gallo; A Franchi; L Magnelli; I Sardi; A Vannacci; V Boddi; V Chiarugi; E Masini
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

4.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts.

Authors:  Dietmar W Siemann; W D Brazelle; Juliane M Jürgensmeier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

6.  Influence of Exposure to Chronic Persistent Low-Dose Ionizing Radiation on the Tumor Biology of Clear-Cell Renal-Cell Carcinoma. An Immunohistochemical and Morphometric Study of Angiogenesis and Vascular Related Factors.

Authors:  Amparo Ruiz-Saurí; Gerardo Valencia-Villa; Alina Romanenko; Jesús Pérez; Raúl García; Heydi García; José Benavent; María Sancho-Tello; Carmen Carda; Antonio Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2016-05-07       Impact factor: 3.201

Review 7.  The role of angiogenesis in prostate and other urologic cancers: a review.

Authors:  J I Izawa; C P Dinney
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

8.  Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.

Authors:  Bernard Paule; Laurence Bastien; Emmanuelle Deslandes; Olivier Cussenot; Marie-Pierre Podgorniak; Yves Allory; Benyoussef Naïmi; Raphael Porcher; Alexandre de La Taille; Suzanne Menashi; Fabien Calvo; Samia Mourah
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma.

Authors:  Börje Ljungberg; Jan Jacobsen; Stina Häggström-Rudolfssson; Torgny Rasmuson; Gudrun Lindh; Kjell Grankvist
Journal:  Urol Res       Date:  2003-09-13

10.  Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.

Authors:  Atsushi Kodama; Hiroki Sakai; Satoko Matsuura; Mami Murakami; Atsuko Murai; Takashi Mori; Kouji Maruo; Tohru Kimura; Toshiaki Masegi; Tokuma Yanai
Journal:  BMC Cancer       Date:  2009-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.